Published by Alexander Bueso on 2nd April 2024
(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).
URL: http://www.digitallook.com/dl/news/story/34192029/...